Study on the Medical Education Capability of the EyeTeacher Artificial Intelligence Platform

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21-40
SponsorTsinghua University

About this trial

With the rise of generative artificial intelligence and large language models, medical education is undergoing a significant transformation. Numerous studies have highlighted the limitations of traditional educational knowledge acquisition and the potential impact of artificial intelligence on medical education, resident training, and continuing education for clinical practitioners. However, there is a lack of real-world experiments on the effectiveness of AI-integrated education.

Artificial intelligence can provide extensive educational resources and tools that are not limited by geographical location or language, thereby lowering the barrier to accessing high-quality medical education and promoting educational equity. Nevertheless, the performance of AI models trained by different medical institutions or healthcare systems may vary.

To offer a more universal, accessible, high-quality, and interconnected educational journey. We have developed a virtual ophthalmology teacher, which developed based on foundational model and large language models. This model, named EyeTeacher provide comprehensive theoretical knowledge and clinical skills enhancement for untrained medical students. To verify the effectiveness of our EyeTeacher across different national ophthalmology education systems and languages, we plan to implement a randomized controlled trial. This trial will assess the clinical capabilities of all participants and explore the advantages and disadvantages of the system compared to traditional teaching methods.

Eligibility criteria

Qualifiers

Clinical medical students who have not taken ophthalmology courses

Age 21-40

Gender not restricted

Sign the informed consent form

Disqualifiers

Refusal of the research protocol.

Participants unwilling or unable to understand and complete the questionnaire.

Trial design

Treatments tested in this trial

  • EyeTeacher

Treatment groups

252 Participants
are divided into 2 treatment groups

Sponsors and collaborators